Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
713 Vitamin B6-mediated lipid metabolic reprogramming as a strategy to restore antitumor T cell immunity in aging
- 14University of Lausanne, Ludwig Institute for Cancer Research, Epalinges, Vaud, Switzerland
- 2University of Fribourg, Fribourg, Switzerland
Related
- Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity.
- NOD2 restrains probiotic-mediated TLR2-dependent antitumor immunity
- Liver-Resident Metabolic Reprogramming and Th2/1 Cell Accumulation Drive Anti-Helminth Immunity During H. bakeri InfectionRunning title: Liver metabolic-immune crosstalk in helminth infection
- CD73-LNPs promote antitumor T-cell immunity via amplifying TLR3-mediated immunostimulatory dendritic cell activation
- A living enzymatic adenosine switch couples metabolic rescue to IL-12-driven antitumor immunity
BibTeX
@article{vannini2026vitamin,
title = {{713 Vitamin B6-mediated lipid metabolic reprogramming as a strategy to restore antitumor T cell immunity in aging}},
author = {Nicola Vannini and Helen Carrasco Hope and Claudia Cifuentes Caballero and Ilaria Delle Fontane and Maria Morbidelli},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0713},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0713},
note = {CC BY},
}
RIS
TY - JOUR
TI - 713 Vitamin B6-mediated lipid metabolic reprogramming as a strategy to restore antitumor T cell immunity in aging
AU - Nicola Vannini
AU - Helen Carrasco Hope
AU - Claudia Cifuentes Caballero
AU - Ilaria Delle Fontane
AU - Maria Morbidelli
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0713
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0713
SN - 2051-1426
ER -